NCT02911285View on ClinicalTrials.gov

NAC for Treating Comorbid PTSD and SUD

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

August 5, 2019

Study Completion Date

November 4, 2019

Conditions
Posttraumatic Stress Disorder (PTSD)Alcohol Use Disorder (AUD)Substance Use Disorder (SUD)
Interventions
DRUG

N-acetylcysteine

1200mg bid (2400mg/day)

DRUG

Placebo

Placebo pills bid

BEHAVIORAL

Cognitive behavioral therapy

CBT for AUD/SUD, one hour/once a week

Trial Locations (2)

29401

Medical University of South Carolina, Charleston

Ralph H Johnson VA Medical Center, Charleston

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

Institute for Translational Neuroscience

UNKNOWN

lead

Medical University of South Carolina

OTHER

NCT02911285 - NAC for Treating Comorbid PTSD and SUD | Biotech Hunter | Biotech Hunter